Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe - PubMed (original) (raw)
Review
doi: 10.1111/j.1469-0691.2012.03821.x.
M Akóva, Y Carmeli, C G Giske, Y Glupczynski, M Gniadkowski, D M Livermore, V Miriagou, T Naas, G M Rossolini, Ø Samuelsen, H Seifert, N Woodford, P Nordmann; European Network on Carbapenemases
Collaborators, Affiliations
- PMID: 22507109
- DOI: 10.1111/j.1469-0691.2012.03821.x
Free article
Review
Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
R Cantón et al. Clin Microbiol Infect. 2012 May.
Free article
Abstract
Plasmid-acquired carbapenemases in Enterobacteriaceae, which were first discovered in Europe in the 1990s, are now increasingly being identified at an alarming rate. Although their hydrolysis spectrum may vary, they hydrolyse most β-lactams, including carbapenems. They are mostly of the KPC, VIM, NDM and OXA-48 types. Their prevalence in Europe as reported in 2011 varies significantly from high (Greece and Italy) to low (Nordic countries). The types of carbapenemase vary among countries, partially depending on the cultural/population exchange relationship between the European countries and the possible reservoirs of each carbapenemase. Carbapenemase producers are mainly identified among Klebsiella pneumoniae and Escherichia coli, and still mostly in hospital settings and rarely in the community. Although important nosocomial outbreaks with carbapenemase-producing Enterobacteriaceae have been extensively reported, many new cases are still related to importation from a foreign country. Rapid identification of colonized or infected patients and screening of carriers is possible, and will probably be effective for prevention of a scenario of endemicity, as now reported for extended-spectrum β-lactamase (mainly CTX-M) producers in all European countries.
© 2012 The Authors. Clinical Microbiology and Infection © 2012 European Society of Clinical Microbiology and Infectious Diseases.
Similar articles
- [Carbapenemases in enterobacteriaceae].
Nordmann P, Carrer A. Nordmann P, et al. Arch Pediatr. 2010 Sep;17 Suppl 4:S154-62. doi: 10.1016/S0929-693X(10)70918-0. Arch Pediatr. 2010. PMID: 20826325 French. - Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe.
Cantón R, Novais A, Valverde A, Machado E, Peixe L, Baquero F, Coque TM. Cantón R, et al. Clin Microbiol Infect. 2008 Jan;14 Suppl 1:144-53. doi: 10.1111/j.1469-0691.2007.01850.x. Clin Microbiol Infect. 2008. PMID: 18154538 Review. - Carbapenemase-producing Enterobacteriaceae: a call for action!
Nordmann P, Cornaglia G. Nordmann P, et al. Clin Microbiol Infect. 2012 May;18(5):411-2. doi: 10.1111/j.1469-0691.2012.03795.x. Clin Microbiol Infect. 2012. PMID: 22507108 No abstract available. - Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge.
Nordmann P. Nordmann P. Med Mal Infect. 2014 Feb;44(2):51-6. doi: 10.1016/j.medmal.2013.11.007. Epub 2013 Dec 18. Med Mal Infect. 2014. PMID: 24360201 Review. - Identification and screening of carbapenemase-producing Enterobacteriaceae.
Nordmann P, Gniadkowski M, Giske CG, Poirel L, Woodford N, Miriagou V; European Network on Carbapenemases. Nordmann P, et al. Clin Microbiol Infect. 2012 May;18(5):432-8. doi: 10.1111/j.1469-0691.2012.03815.x. Clin Microbiol Infect. 2012. PMID: 22507110 Review.
Cited by
- Ceftazidime-avibactam treatment dilemma of blaKPC-2-containing Klebsiella pneumoniae due to the development of co-existence of mixed strains carrying blaKPC-2 or blaKPC-33 in lung transplant recipients.
Lei Z, Li Z, Zhang Y, Zeng L, Wu Y, Zhang F, Yang X, Liu X, Liu Q, Ma Y, Lu B. Lei Z, et al. Ann Clin Microbiol Antimicrob. 2024 Nov 8;23(1):99. doi: 10.1186/s12941-024-00743-x. Ann Clin Microbiol Antimicrob. 2024. PMID: 39516891 Free PMC article. - Prevalence, Characterization, and Epidemiological Relationships between ESBL and Carbapenemase-Producing Escherichia coli, Klebsiella pneumoniae, and Acinetobacter spp. Isolated from Humans and the Kitchen Environment of Two Greek Hospitals.
Tsitsos A, Damianos A, Boutel M, Gousia P, Soultos N, Papa A, Tirodimos I, Economou V. Tsitsos A, et al. Antibiotics (Basel). 2024 Oct 2;13(10):934. doi: 10.3390/antibiotics13100934. Antibiotics (Basel). 2024. PMID: 39452201 Free PMC article. - AMR and Sustainable Development Goals: at a crossroads.
Aslam B, Asghar R, Muzammil S, Shafique M, Siddique AB, Khurshid M, Ijaz M, Rasool MH, Chaudhry TH, Aamir A, Baloch Z. Aslam B, et al. Global Health. 2024 Oct 17;20(1):73. doi: 10.1186/s12992-024-01046-8. Global Health. 2024. PMID: 39415207 Free PMC article. Review. - Rapid Reversal of Carbapenemase-Producing Pseudomonas aeruginosa Epidemiology from _bla_VIM- to _bla_NDM-harbouring Isolates in a Greek Tertiary Care Hospital.
Protonotariou E, Meletis G, Vlachodimou N, Malousi A, Tychala A, Katsanou C, Daviti A, Mantzana P, Skoura L. Protonotariou E, et al. Antibiotics (Basel). 2024 Aug 12;13(8):762. doi: 10.3390/antibiotics13080762. Antibiotics (Basel). 2024. PMID: 39200062 Free PMC article. - Plasmid-Mediated Spread of Carbapenem Resistance in Enterobacterales: A Three-Year Genome-Based Survey.
Yao Y, Imirzalioglu C, Falgenhauer L, Falgenhauer J, Heinmüller P; SurvCARE Hesse Working Group; Domann E, Chakraborty T. Yao Y, et al. Antibiotics (Basel). 2024 Jul 23;13(8):682. doi: 10.3390/antibiotics13080682. Antibiotics (Basel). 2024. PMID: 39199982 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous